Kyoto’s CiRA and MicroBiopharm Japan discover Actinomyces metabolites which reduce amyloid-ß (Aß) formation in-vitro, relation to gut microbiota inferred Apr 5, 2022 https://bio.nikkeibp.co.jp/atcl/news/p1/22/04/04/09336/